Non-animal glioblastoma models for personalized treatment

por Zottel, Alja, Jovčevska, Ivana, Šamec, Neja
Publicado 2023

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

por Šamec, Neja, Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Publicado 2020

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

por Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana
Publicado 2020

Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles

por Colja, Sara, Jovčevska, Ivana, Šamec, Neja, Romih, Rok, Zottel, Alja
Publicado 2023

OligoPrime: An Information System for Oligonucleotide Management

por Ravnik, Šimen, Žabkar, Ines, Prosenc Zmrzljak, Uršula, Jovčevska, Ivana, Šamec, Neja, Moškon, Miha, Videtič Paska, Alja
Publicado 2021

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas

por Jovčevska, Ivana, Zottel, Alja, Šamec, Neja, Mlakar, Jernej, Sorokin, Maxim, Nikitin, Daniil, Buzdin, Anton A., Komel, Radovan
Publicado 2019

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

por Zottel, Alja, Jovčevska, Ivana, Šamec, Neja, Mlakar, Jernej, Šribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, Radovan
Publicado 2020

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates

por Vidak, Marko, Jovcevska, Ivana, Samec, Neja, Zottel, Alja, Liovic, Mirjana, Rozman, Damjana, Dzeroski, Saso, Juvan, Peter, Komel, Radovan
Publicado 2018

Current Technologies for RNA-Directed Liquid Diagnostics

por Martinez-Dominguez, Maria Victoria, Zottel, Alja, Šamec, Neja, Jovčevska, Ivana, Dincer, Can, Kahlert, Ulf Dietrich, Nickel, Ann-Christin
Publicado 2021

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

por Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Publicado 2018

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion

por Porčnik, Andrej, Novak, Metka, Breznik, Barbara, Majc, Bernarda, Hrastar, Barbara, Šamec, Neja, Zottel, Alja, Jovčevska, Ivana, Vittori, Miloš, Rotter, Ana, Komel, Radovan, Lah Turnšek, Tamara
Publicado 2021

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

por Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Publicado 2021

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles

por Zottel, Alja, Šamec, Neja, Kump, Ana, Dall’Olio, Lucija Raspor, Pužar Dominkuš, Pia, Romih, Rok, Hudoklin, Samo, Mlakar, Jernej, Nikitin, Daniil, Sorokin, Maxim, Buzdin, Anton, Jovčevska, Ivana, Komel, Radovan
Publicado 2020

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo

por Zottel, Alja, Novak, Metka, Šamec, Neja, Majc, Bernarda, Colja, Sara, Katrašnik, Mojca, Vittori, Miloš, Hrastar, Barbara, Rotter, Ana, Porčnik, Andrej, Lah Turnšek, Tamara, Komel, Radovan, Breznik, Barbara, Jovčevska, Ivana
Publicado 2023

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas

por Zolotovskaia, Marianna, Tkachev, Victor, Sorokin, Maxim, Garazha, Andrew, Kim, Ella, Kantelhardt, Sven Rainer, Bikar, Sven-Ernö, Zottel, Alja, Šamec, Neja, Kuzmin, Denis, Sprang, Bettina, Moisseev, Alexey, Giese, Alf, Efimov, Victor, Jovčevska, Ivana, Buzdin, Anton
Publicado 2021